Cytori Cell Research Institute, Inc.

3750

JP3426500009

Real Estate Services

Market Closed - Japan Exchange Other stock markets 01:49:23 2024-05-21 am EDT			5-day change	1st Jan Change
979 ^JPY	+0.93%		-0.51%	-14.05%

Mar. 13	Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc..	CI
2023	Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Rights Issue: 2 new shares @ 1600 JPY for 1 existing share

December 19, 2013

MarketScreener.com By

Latest news about Cytori Cell Research Institute, Inc.

Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc..	Mar. 12	CI
Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
Sakurajyuji Co., Ltd. signed an agreement to acquire approximately 1.60% stake in FRACTALE Corporation (TSE : 3750) from Aqua Strategic Investment Business Limited Partnership, managed by ACA Inc. for approximately ¥200 million.	21-12-26	CI
FRACTALE Corporation canceled the acquisition of Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd.	21-05-14	CI
FRACTALE Corporation announced that it has received ¥12.675 million in funding from Japan International Partners LLC	21-01-12	CI
FRACTALE Corporation announced that it expects to receive ¥12.675 million in funding from Japan International Partners LLC	20-12-27	CI
FRACTALE Corporation acquired 91% stake in Alegrox Hotel Management Co., Ltd from Shinji Ezure and others for ¥21.2 million.	20-07-02	CI
FRACTALE Corporation agreed to acquire the remaining 43.63% stake in Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. for ¥2.1 billion.	20-05-14	CI
Osaka Mokuzai Sougo Ichiba Co., Ltd. cancelled the acquisition of Ikeda Fudosan Co., Ltd. from FRACTALE Corporation.	20-02-24	CI
Seijiro Shirahama and FRACTALE Corporation completed the acquisition of Cytori Therapeutics K.K. and Cell Therapy Assets in Japan.	19-04-24	CI
Seijiro Shirahama entered into an asset and equity purchase agreement to acquire Cytori Therapeutics K.K. and Cell Therapy Assets in Japan for $3 million.	19-04-22	CI
An individual cancelled the acquisition of International Luxury Media Co., Ltd. from Seven Seas Holdings Co.,Ltd..	19-02-25	CI
Osaka Mokuzai Sougo Ichiba Co., Ltd. signed a contract to acquire Ikeda Fudosan Co., Ltd. from FRACTALE Corporation for ¥1.7 billion.	19-02-24	CI
Seven Seas Holdings Co.,Ltd. cancelled the acquisition of Nuts Real Estate LLC from Nuts Real Estate Institute.	18-11-26	CI
An individual agreed to acquire International Luxury Media Co., Ltd. from Seven Seas Holdings Co.,Ltd. for ¥10 million.	18-02-25	CI
Seven Seas Holdings Co.,Ltd. cancelled the acquisition of Sengokuhara Development Co., Ltd.	18-02-08	CI
Tranche Update on Seven Seas Holdings Co.,Ltd.'s Equity Buyback Plan announced on June 22, 2017.	17-12-26	CI
Seven Seas Holdings Co.,Ltd.'s Equity Buyback announced on June 22, 2017 has expired with 52,700 shares for ¥89.58 million.	17-12-25	CI
Seven Seas Holdings Co.,Ltd. agreed to acquire Nuts Real Estate LLC from Nuts Real Estate Institute for ¥0.3 million.	17-11-26	CI
Nuts Real Estate LLC agreed to acquire Sengokuhara Development Co., Ltd. for ¥0.2 million.	17-11-26	CI
Aqua Strategic Investment Business Limited Partnership, managed by ACA Inc. completed the acquisition of 62.5% stake in Seven Seas Holdings Co.,Ltd..	17-10-31	CI
Aqua Strategic Investment Business Limited Partnership, managed by ACA Inc. launched a tender offer to acquire 62.5% stake in Seven Seas Holdings Co.,Ltd. for ¥1.8 billion.	17-10-02	CI
Tranche Update on Seven Seas Holdings Co.,Ltd.'s Equity Buyback Plan announced on June 22, 2017.	17-10-02	CI
Tranche Update on Seven Seas Holdings Co.,Ltd.'s Equity Buyback Plan announced on June 22, 2017.	17-06-30	CI
Seven Seas Holdings Co.,Ltd. announces an Equity Buyback for 200,000 shares, representing 13.92% for ¥300 million.	17-06-22	CI

Chart Cytori Cell Research Institute, Inc.

Duration

Period

Chart Cytori Cell Research Institute, Inc.

More charts

Cytori Cell Research Institute Inc is a Japan-based company mainly engaged in the real asset business. The Company operates through two segments. The Real Asset segment is engaged in the purchase and sales of real estate and investment of real estate business related projects, as well as development, renovation and opening of hotels, and operation of hotels. The Medical segment is engaged in the investment of regenerative medicine business centered on cell therapy services, as well as sales of medical equipment and consumables. The main products include Celusion centrifuge and the Celusion cell therapy kit.

Sector

Real Estate Services

Calendar

2024-08-06 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
CYTORI CELL RESEARCH INSTITUTE, INC.	-14.05%	55.49M
CBRE GROUP, INC.	-2.87%	27.2B
KE HOLDINGS INC.	+16.66%	23.18B
CAPITALAND INVESTMENT LIMITED	-15.19%	10.2B
ZILLOW GROUP, INC.	-26.30%	10.16B
JONES LANG LASALLE INCORPORATED	+5.91%	9.61B
FIRSTSERVICE CORPORATION	-6.25%	6.68B
COLLIERS INTERNATIONAL GROUP INC.	-6.93%	5.82B
MAKKAH CONSTRUCTION AND DEVELOPMENT COMPANY	+23.15%	4B
CUSHMAN & WAKEFIELD PLC	+1.48%	2.62B

Other Real Estate Services

Cytori Cell Research Institute, Inc.

Equities

3750

JP3426500009

Real Estate Services

Rights Issue: 2 new shares @ 1600 JPY for 1 existing share

Latest news about Cytori Cell Research Institute, Inc.

Chart Cytori Cell Research Institute, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Real Estate Services